Etoricoxib (arcoxia) in rheumatology

The paper gives information on the selective COX-2 inhibitor etoricoxib registered for use in many countries of the world. It gives a brief description of a few key trials of the efficacy and tolerability of etoricoxib in rheumatology

Bibliographic Details
Main Authors: Fatima Magomedovna Kudaeva, V G Barskova, Fatima Magomedovna Kudayeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2011-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/356
id doaj-44bad5bc0af041e38326e00c3fbe8a69
record_format Article
spelling doaj-44bad5bc0af041e38326e00c3fbe8a692021-07-29T09:00:07ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2011-06-0152616410.14412/1996-7012-2011-6711661Etoricoxib (arcoxia) in rheumatologyFatima Magomedovna KudaevaV G BarskovaFatima Magomedovna KudayevaV G BarskovaThe paper gives information on the selective COX-2 inhibitor etoricoxib registered for use in many countries of the world. It gives a brief description of a few key trials of the efficacy and tolerability of etoricoxib in rheumatologyhttps://mrj.ima-press.net/mrj/article/view/356nonsteroidal anti-inflammatory drugsrheumatic diseasesetoricoxib
collection DOAJ
language Russian
format Article
sources DOAJ
author Fatima Magomedovna Kudaeva
V G Barskova
Fatima Magomedovna Kudayeva
V G Barskova
spellingShingle Fatima Magomedovna Kudaeva
V G Barskova
Fatima Magomedovna Kudayeva
V G Barskova
Etoricoxib (arcoxia) in rheumatology
Современная ревматология
nonsteroidal anti-inflammatory drugs
rheumatic diseases
etoricoxib
author_facet Fatima Magomedovna Kudaeva
V G Barskova
Fatima Magomedovna Kudayeva
V G Barskova
author_sort Fatima Magomedovna Kudaeva
title Etoricoxib (arcoxia) in rheumatology
title_short Etoricoxib (arcoxia) in rheumatology
title_full Etoricoxib (arcoxia) in rheumatology
title_fullStr Etoricoxib (arcoxia) in rheumatology
title_full_unstemmed Etoricoxib (arcoxia) in rheumatology
title_sort etoricoxib (arcoxia) in rheumatology
publisher IMA-PRESS LLC
series Современная ревматология
issn 1996-7012
2310-158X
publishDate 2011-06-01
description The paper gives information on the selective COX-2 inhibitor etoricoxib registered for use in many countries of the world. It gives a brief description of a few key trials of the efficacy and tolerability of etoricoxib in rheumatology
topic nonsteroidal anti-inflammatory drugs
rheumatic diseases
etoricoxib
url https://mrj.ima-press.net/mrj/article/view/356
work_keys_str_mv AT fatimamagomedovnakudaeva etoricoxibarcoxiainrheumatology
AT vgbarskova etoricoxibarcoxiainrheumatology
AT fatimamagomedovnakudayeva etoricoxibarcoxiainrheumatology
AT vgbarskova etoricoxibarcoxiainrheumatology
_version_ 1721250407969193984